SavedAdd your journal

Journals / Eastern Journal of Medicine / 2020 / Cilt: 25 - Sayı: 2

Human Chorionic Gonadotropin Levels 0/1-4 Days After Methotrexate Administration For Predicting Ectopic Pregnancy Treatment Success

Gültekin ADANAŞ AYDIN
Gülten ÖZGEN
Pages
278–284
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Changes in hCG levels between Days 0/1-4 and 4-7 were calculated.The overall success rate of single-dose MTX treatment was found to be 71.6%.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Ectopic pregnancy is one of the major causes of morbidity and mortality, accounting for 1 to 2% of all pregnancies.
📊
Key Findings & Data:With the introduction of recent developments in diagnostic tools, the success rate of medical treatment has increased.
💡
Conclusion & Impact:Changes in hCG levels between Days 0/1-4 and 4-7 were calculated.The overall success rate of single-dose MTX treatment was found to be 71.6%.
🔬Design:Research Article
📍Scope:2016 Verileri
⚙️Variables:Domain Parameters

Özet

Ectopic pregnancy is one of the major causes of morbidity and mortality, accounting for 1 to 2% of all pregnancies. With the introduction of recent developments in diagnostic tools, the success rate of medical treatment has increased. The treatment is considered successful, if there is a 15% decline in serum human chorionic gonadotropin (hCG) levels between Days 4 and 7 of follow up in patients receiving single-dose methotrexate (MTX) treatment. In the present study, we aimed to determine whether the change in hCG levels between Days 0 and 4 is useful in predicting treatment success in patients receiving single-dose MTX protocol.A total of 93 patients who were diagnosed with ectopic pre gnancy in our clinic between September 2016 and September 2018 and treated with MTX were retrospectively analyzed. Changes in hCG levels between Days 0/1-4 and 4-7 were calculated.The overall success rate of single-dose MTX treatment was found to be 71.6%. A total of 50 patients of the success group had decreased hCG levels on Day 4, while only 18 patients of the success group had increased hCG levels on Day 4. Using the cut -off value for hCG change between Days 1 and 4, a decrease of 16.1% in hCG levels was found to be the strongest predictor of treatment success. The sensitivity, specificity, and positive predictive value of this cut-off value were 89.7%, 64%, and 87.1%, respectively. In conclusion, early changes in hCG levels may be useful in the follow-up of the treatment success.

🔖

Cite This Article

AYDIN, G. A., ÖZGEN, G. (2020). Human Chorionic Gonadotropin Levels 0/1-4 Days After Methotrexate Administration For Predicting Ectopic Pregnancy Treatment Success. Eastern Journal of Medicine, Cilt: 25 - Sayı: 2, 278–284. https://ajindex.com/articles/158318

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Hajenius PJ, Mol F, Mol BW, et al. Interventions for tubal ectopic pregnancy. Cochrane Database Syst Rev 2007 10.1002/14651858.CD000324. Berg CJ, Callaghan WM, Henderson Z, et al. Pregnancy-related mortality in the United States, 1998 to 2005. Obstet Gynecol 2010; 116: 1302-1309.
  2. Creanga AA, Shapiro-Mendoza CK, Bish CL, Zane S, Berg CJ, Callaghan W.M. Trends in ectopic pregnancy mortality in the United States: 1980-2007. Obstet. Gynecol 2011; 117: 837-843.
  3. Zane SB, Kieke BA, Kendrick JS, Bruce C. Surveillance in a time of changing health care practices: estimating ectopic pregnancy incidence in the United States. Matern. Child Health J 2002; 6: 227-236.
  4. Westaby DT, Wu O, Duncan WC, Critchley HO, Tong S, Horne AW. Has increased clinical experience with methotrexate reduced the direct costs of medical management of ectopic pregnancy compared to surgery?. BMC Pregnancy Childbirth 2012; 12: 98. Levin G, Dior U, Shushan A, Gilad R, Benshushan A, Rottenstreich A. Early prediction of the success of methotrexate treatment success by 24-hour pretreatment increment in HCG and day 1-4 change in HCGReprod Biomed Online 2019; 39: 149-154.
  5. Yang C, Cai J, Geng Y, Gao Y. Multiple-dose and double-dose versus single-dose administration of methotrexate for the treatment of ectopic pregnancy: a systematic review and meta-analysis. Reprod. Biomed. Online 2017; 34: 383-391.
  6. Stovall TG, Ling FW, Gray LA. Single-dose methotrexate for treatmentof ectopic pregnancy.Obstet Gynecol 1991; 77: 754-757.
  7. Kirk E, Condous G, Van Calster B, et al. A validation of the most commonly used protocol topredict the success of single-dose methotrexate in the treatment ofectopic pregnancy.Hum Reprod 2007; 22: 858-863.
  8. Stovall TG, Ling FW. Single-dose methotrexate: An expanded clinical trial. Am J Obstet Gynecol 1993; 168: 1759-1765.
  9. Barnhart KT, Gosman G, Ashby R, Sammel M. The medical management of ectopic pregnancy: A meta-analysis comparing “single dose” and “multidose” regimens. Obstet Gynecol 2003; 101: 778-784.
  10. Lipscomb GH, Givens VM, Meyer NL, Bran D. Comparison of multidose and single-dose methotrexate protocols for the treatment of ectopic pregnancy. Am J Obstet Gynecol 2005; 192: 1844-1848.
  11. Kirk E, Condous G, Bourne T. The non-surgical management of ectopic pregnancy. Ultrasound Obstet Gynecol 2006; 27: 91-100.
  12. Skubisz MM, Dutton P, Duncan WC, Horne AW, Tong S. Using a decline in serum hCG between days 0-4 to predict ectopic pregnancy treatment success after single-dose methotrexate: a ret